Welcome to LookChem.com Sign In|Join Free
  • or

Encyclopedia

Ranitidinebismuthcitrate

Base Information Edit
  • Chemical Name:Ranitidinebismuthcitrate
  • CAS No.:128345-62-0
  • Molecular Formula:C13H22N4O3S•C6H5BiO7
  • Molecular Weight:712.49
  • Hs Code.:
  • Mol file:128345-62-0.mol
Ranitidinebismuthcitrate

Synonyms:RANTIDINEBISMUTHCITRATE

Suppliers and Price of Ranitidinebismuthcitrate
Supply Marketing:Edit
Business phase:
The product has achieved commercial mass production*data from LookChem market partment
Manufacturers and distributors:
  • Manufacture/Brand
  • Chemicals and raw materials
  • Packaging
  • price
  • AvaChem
  • Ranitidine bismuth citrate
  • 100mg
  • $ 290.00
  • American Custom Chemicals Corporation
  • RANITIDINE BISMUTH CITRATE 95.00%
  • 5MG
  • $ 505.82
Total 36 raw suppliers
Chemical Property of Ranitidinebismuthcitrate Edit
Chemical Property:
  • Vapor Pressure:7.66E-08mmHg at 25°C 
  • Boiling Point:437.1°Cat760mmHg 
  • Flash Point:218.2°C 
  • PSA:252.18000 
  • Density:1.184g/cm3 
  • LogP:-2.48860 
Purity/Quality:

99% *data from raw suppliers

Ranitidine bismuth citrate *data from reagent suppliers

Safty Information:
  • Pictogram(s): A poison by ingestion. 
  • Hazard Codes:A poison by ingestion. 
MSDS Files:

SDS file from LookChem

Useful:
  • Description Ranitidine bismuth citrate, a novel salt formed from ranitidine and a bismuth citrate complex, is a new agent introduced in the United Kingdom for the treatment of duodenal and benign gastric ulcers, for eradication of Helicobacfer pylori, and for prevention of relapse of duodenal ulcer when administered in combination with an antibiotic such as clarithromycin or amoxicillin. Ranitidine is a potent histamine H2-receptor antagonist with ability to inhibit gastric acid secretion. Other type of agents such as tripotassium dicitrato bismuthate exert their therapeutic effects in peptic ulceration by providing a protective coating to the ulcer crater, stimulating endogenous prostaglandin production, and inhibiting pepsin activity. More significantly, they inhibit micro-organism Helicobacfer pylori, a prevalent, specifically human pathogen associated with gastritis and gastric ulcers. The title compound possesses a novel combination of properties of the above two types of drugs and displays excellent therapeutic efficacy in clinical studies. Ranitidine bismuth citrate is being investigated for use in gastritis and non-ulcerating dyspepsia, acute healing of gastrointestinal ulcer and in prevention of the recurrence of peptic ulcer disease.
  • Uses Antagonist (to histamine H2receptors).
Post RFQ for Price